Addex Therapeutics (ADXN) Receivables (2022 - 2025)
Historic Receivables for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $64062.6.
- Addex Therapeutics' Receivables fell 8925.41% to $64062.6 in Q3 2025 from the same period last year, while for Sep 2025 it was $64062.6, marking a year-over-year decrease of 8925.41%. This contributed to the annual value of $26689.8 for FY2024, which is 8415.36% down from last year.
- According to the latest figures from Q3 2025, Addex Therapeutics' Receivables is $64062.6, which was down 8925.41% from $46430.1 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Receivables ranged from a high of $681642.1 in Q2 2024 and a low of $26802.9 during Q4 2024
- Moreover, its 4-year median value for Receivables was $425724.0 (2022), whereas its average is $350499.4.
- In the last 5 years, Addex Therapeutics' Receivables soared by 4103.35% in 2024 and then tumbled by 9318.85% in 2025.
- Quarter analysis of 4 years shows Addex Therapeutics' Receivables stood at $557287.9 in 2022, then crashed by 69.4% to $170532.7 in 2023, then crashed by 84.28% to $26802.9 in 2024, then soared by 139.01% to $64062.6 in 2025.
- Its last three reported values are $64062.6 in Q3 2025, $46430.1 for Q2 2025, and $39330.3 during Q1 2025.